Michael Pishvaian

No bio available.

Financial relationships

  • Attribution:
    Self
    Type of financial relationship:
    Independent contractor
    Ineligible company:
    Astra Zeneca
    Topic:
    PARP Inhibitors
    Date added:
    03/14/2024
    Date updated:
    03/14/2024
  • Attribution:
    Self
    Type of financial relationship:
    Independent contractor
    Ineligible company:
    Ideaya
    Topic:
    PARG inhibitors
    Date added:
    03/14/2024
    Date updated:
    03/14/2024
  • Attribution:
    Self
    Type of financial relationship:
    Independent contractor
    Ineligible company:
    Seattle Genetics
    Topic:
    HER2 Amplification
    Date added:
    03/14/2024
    Date updated:
    03/14/2024
  • Attribution:
    Self
    Type of financial relationship:
    Independent contractor
    Ineligible company:
    Merus
    Topic:
    NRG1 fusions
    Date added:
    03/14/2024
    Date updated:
    03/14/2024
  • Attribution:
    Self
    Type of financial relationship:
    Independent contractor
    Ineligible company:
    Merck
    Topic:
    Immuotherapy
    Date added:
    03/14/2024
    Date updated:
    03/14/2024
  • Attribution:
    Self
    Type of financial relationship:
    Independent contractor
    Ineligible company:
    Moderna
    Topic:
    Vaccines
    Date added:
    03/14/2024
    Date updated:
    03/14/2024
  • Attribution:
    Self
    Type of financial relationship:
    Independent contractor
    Ineligible company:
    Pfizer
    Topic:
    Pancreatic Cancer CME
    Date added:
    03/14/2024
    Date updated:
    03/14/2024
  • Attribution:
    Self
    Type of financial relationship:
    Independent contractor
    Ineligible company:
    Novartis
    Topic:
    Pancreatic Cancer CME
    Date added:
    03/14/2024
    Date updated:
    03/14/2024
  • Attribution:
    Self
    Type of financial relationship:
    Independent contractor
    Ineligible company:
    Astellas
    Topic:
    Pancreatic Cancer CME
    Date added:
    03/14/2024
    Date updated:
    03/14/2024
  • Attribution:
    Self
    Type of financial relationship:
    Grant Or Contract
    Ineligible company:
    Astellas
    Topic:
    Steering Committee
    Date added:
    03/14/2024
    Date updated:
    03/14/2024

Pages

Return to Pancreatic Cancer Symposium (RP2404B)

 

**Disclaimer**

This Continuing Medical Education (CME) Learning Management System, Ethos, includes individuals designated as 'faculty' for CME purposes. Please note that the term 'faculty' refers solely to their role as a contributor/planner within a CME activity and does not imply any formal affiliation with UT Southwestern Medical Center (UTSW). The display of names and credentials is intended for educational purposes only and does not necessarily indicate a professional or academic relationship with UTSW. Participants are encouraged to verify the affiliations and credentials of faculty members independently if further clarification is needed.